Peptobiotics, a pioneering Singaporean startup focused on livestock disease prevention and enhancing sustainable agricultural productivity through synthetic biology innovations, has successfully raised an impressive $6.2 million in its latest funding round. The company, which harnesses cutting-edge biotechnology to develop natural peptides aimed at improving animal health and performance, attracted the attention of EF Venture Capital, a strategic investor known for its commitment to groundbreaking agri-tech advancements. This injection of capital will significantly bolster Peptobiotics’ research and development efforts, allowing the team to accelerate the production of their innovative pet biotics products and expand their market reach. The funds will also be pivotal in scaling up their operations, enhancing manufacturing capabilities, and driving forward their mission to transform livestock management practices. With an urgent global focus on sustainable farming and food security, Peptobiotics aims to address some of the agriculture sector’s most pressing challenges, such as disease outbreaks and antibiotic dependency. By leveraging their proprietary technology and scientific expertise, the company is poised to revolutionize livestock health management, ultimately leading to healthier animals, increased productivity, and a reduced environmental footprint. As the agricultural landscape continues to evolve, Peptobiotics is on the forefront of delivering sustainable solutions that not only improve farm viability but also contribute to a more resilient food system. This funding round marks a significant milestone for the company and positions Peptobiotics for robust growth and impact in the agri-tech sector.










.png&w=3840&q=75)


